Interaction between IGF-1 polymorphisms and overweight for the risk of pancreatic cancer in Japanese

International Journal of Molecular Epidemiology and Genetics

Volumn 2, Issue 4, 2011, Pages 354-366

  Nakao, Makoto ^a,b   Hosono, Satoyo ^a   Ito, Hidemi ^a   Watanabe, Miki ^a   Mizuno, Nobumasa ^a   Yatabe, Yasushi ^a   Yamao, Kenji ^a   Ueda, Ryuzo ^b   Tajima, Kazuo ^a   Tanaka, Hideo ^a,c   Matsuo, Keitaro ^a,c  

^a AICHI CANCER CENTER HOSPITAL   (Japan)

^b NAGOYA CITY UNIVERSITY GRADUATE SCHOOL OF MEDICAL SCIENCES   (Japan)

^c NAGOYA UNIVERSITY GRADUATE SCHOOL OF MEDICINE   (Japan)

Author keywords

IGF 1; Overweight; Pancreatic cancer; Risk factor; SNPs

Indexed keywords

SOMATOMEDIN C;

ADULT; AGED; ALLELE; ARTICLE; BODY MASS; CANCER RISK; CASE CONTROL STUDY; CLINICAL OBSERVATION; CONTROLLED STUDY; FEMALE; GENE FREQUENCY; GENE INTERACTION; GENETIC ASSOCIATION; HAPLOTYPE; HUMAN; JAPANESE; LOGISTIC REGRESSION ANALYSIS; MAJOR CLINICAL STUDY; MALE; OBESITY; PANCREAS CANCER; PROTEIN POLYMORPHISM; QUESTIONNAIRE; RISK FACTOR; SINGLE NUCLEOTIDE POLYMORPHISM;

EID: 83655183072     PISSN: None     EISSN: 19481756     Source Type: Journal    
DOI: None     Document Type: Article

References (39)

1. Center for Cancer Control and Information Services. Japan: N.C.C. Center for Cancer Control and Information Services, National Cancer Center 2007.
2. Kanda J, Matsuo K, Suzuki T, Kawase T, Hiraki A, Watanabe M, Mizuno N, Sawaki A, Yamao K, Tajima K and Tanaka H. Impact of alcohol consumption with polymorphisms in alcoholmetabolizing enzymes on pancreatic cancer risk in Japanese. Cancer Sci 2009; 100: 296-302.
3. Matsuda T, Marugame T, Kamo K, Katanoda K, Ajiki W and Sobue T. Cancer incidence and incidence rates in Japan in 2003: based on data from 13 population-based cancer registries in the Monitoring of Cancer Incidence in Japan (MCIJ) Project. Jpn J Clin Oncol 2009; 39: 850-858.
4. Tsugane S, Inoue M. Insulin resistance and cancer: epidemiological evidence. Cancer Sci 2010; 101: 1073-1079.
5. Low SK, Kuchiba A, Zembutsu H, Saito A, Takahashi A, Kubo M, Daigo Y, Kamatani N, Chiku S, Totsuka H, Ohnami S, Hirose H, Shimada K, Okusaka T, Yoshida T, Nakamura Y and Sakamoto H. Genome-wide association study of pancreatic cancer in Japanese population. PLoS One 2010; 5: e11824.
6. Tsukuma H, Ajiki W, Ioka A and Oshima A. Survival of cancer patients diagnosed between 1993 and 1996: a collaborative study of population- based cancer registries in Japan. Jpn J Clin Oncol 2006; 36: 602-607.
7. Lowenfels AB, Maisonneuve P. Epidemiology and risk factors for pancreatic cancer. Best Pract Res Clin Gastroenterol 2006; 20: 197-209.
8. Lin Y, Kikuchi S, Tamakoshi A, Yagyu K, Obata Y, Inaba Y, Kurosawa M, Kawamura T, Motohashi Y and Ishibashi T. Obesity, physical activity and the risk of pancreatic cancer in a large Japanese cohort. Int J Cancer 2007; 120: 2665-2671.
9. Lowenfels AB, Maisonneuve P, Cavallini G, Ammann RW, Lankisch PG, Andersen JR, Dimagno EP, Andren-Sandberg A and Domellof L. Pancreatitis and the risk of pancreatic cancer. International Pancreatitis Study Group. N Engl J Med 1993; 328: 1433-1437.
10. Larsson SC, Orsini N and Wolk A. Body mass index and pancreatic cancer risk: A metaanalysis of prospective studies. Int J Cancer 2007; 120: 1993-1998.
11. Inoue M, Tajima K, Takezaki T, Hamajima N, Hirose K, Ito H and Tominaga S. Epidemiology of pancreatic cancer in Japan: a nested casecontrol study from the Hospital-based Epidemiologic Research Program at Aichi Cancer Center (HERPACC). Int J Epidemiol 2003; 32: 257-262.
12. Hruban RH, Canto MI, Goggins M, Schulick R and Klein AP. Update on familial pancreatic cancer. Advances in surgery 2010; 44: 293-311.
13. Suzuki H, Li Y, Dong X, Hassan MM, Abbruzzese JL and Li D. Effect of insulin-like growth factor gene polymorphisms alone or in interaction with diabetes on the risk of pancreatic cancer. Cancer epidemiology, biomarkers & prevention: a publication of the American Association for Cancer Research, cosponsored by the American Society of Preventive Oncology 2008; 17: 3467-3473.
14. Dong X, Javle M, Hess KR, Shroff R, Abbruzzese JL and Li D. Insulin-like growth factor axis gene polymorphisms and clinical outcomes in pancreatic cancer. Gastroenterology 2010; 139: 464-473, 473 e461-463.
15. Ma J, Pollak MN, Giovannucci E, Chan JM, Tao Y, Hennekens CH and Stampfer MJ. Prospective study of colorectal cancer risk in men and plasma levels of insulin-like growth factor (IGF)- I and IGF-binding protein-3. Journal of the National Cancer Institute 1999; 91: 620-625.
16. Wong HL, Delellis K, Probst-Hensch N, Koh WP, Van Den Berg D, Lee HP, Yu MC and Ingles SA. A new single nucleotide polymorphism in the insulin-like growth factor I regulatory region associates with colorectal cancer risk in singapore chinese. Cancer epidemiology, biomarkers & prevention: a publication of the American Association for Cancer Research, cosponsored by the American Society of Preventive Oncology 2005; 14: 144-151.
17. Canzian F, McKay JD, Cleveland RJ, Dossus L, Biessy C, Rinaldi S, Landi S, Boillot C, Monnier S, Chajes V, Clavel-Chapelon F, Tehard B, Chang-Claude J, Linseisen J, Lahmann PH, Pischon T, Trichopoulos D, Trichopoulou A, Zilis D, Palli D, Tumino R, Vineis P, Berrino F, Buenode- Mesquita HB, van Gils CH, Peeters PH, Pera G, Ardanaz E, Chirlaque MD, Quiros JR, Larranaga N, Martinez-Garcia C, Allen NE, Key TJ, Bingham SA, Khaw KT, Slimani N, Norat T, Riboli E and Kaaks R. Polymorphisms of genes coding for insulin-like growth factor 1 and its major binding proteins, circulating levels of IGFI and IGFBP-3 and breast cancer risk: results from the EPIC study. British journal of cancer 2006; 94: 299-307.
18. Al-Zahrani A, Sandhu MS, Luben RN, Thompson D, Baynes C, Pooley KA, Luccarini C, Munday H, Perkins B, Smith P, Pharoah PD, Wareham NJ, Easton DF, Ponder BA and Dunning AM. IGF1 and IGFBP3 tagging polymorphisms are associated with circulating levels of IGF1, IGFBP3 and risk of breast cancer. Human molecular genetics 2006; 15: 1-10.
19. Missmer SA, Haiman CA, Hunter DJ, Willett WC, Colditz GA, Speizer FE, Pollak MN and Hankinson SE. A sequence repeat in the insulin-like growth factor-1 gene and risk of breast cancer. International journal of cancer. Journal international du cancer 2002; 100: 332-336.
20. Cheng I, Stram DO, Penney KL, Pike M, Le Marchand L, Kolonel LN, Hirschhorn J, Altshuler D, Henderson BE and Freedman ML. Common genetic variation in IGF1 and prostate cancer risk in the Multiethnic Cohort. Journal of the National Cancer Institute 2006; 98: 123-134.
21. Hernandez W, Grenade C, Santos ER, Bonilla C, Ahaghotu C and Kittles RA. IGF-1 and IGFBP-3 gene variants influence on serum levels and prostate cancer risk in African-Americans. Carcinogenesis 2007; 28: 2154-2159.
22. [] Ennishi D, Shitara K, Ito H, Hosono S, Watanabe M, Ito S, Sawaki A, Yatabe Y, Yamao K, Tajima K, Tanimoto M, Tanaka H, Hamajima N and Matsuo K. Association between insulin-like growth factor-1 polymorphisms and stomach cancer risk in a Japanese population. Cancer science 2011; [Epub ahead of print].
23. Bergmann U, Funatomi H, Yokoyama M, Beger HG and Korc M. Insulin-like growth factor I overexpression in human pancreatic cancer: evidence for autocrine and paracrine roles. Cancer research 1995; 55: 2007-2011.
24. Stoeltzing O, Liu W, Reinmuth N, Fan F, Parikh AA, Bucana CD, Evans DB, Semenza GL and Ellis LM. Regulation of hypoxia-inducible factor- 1alpha, vascular endothelial growth factor, and angiogenesis by an insulin-like growth factor-I receptor autocrine loop in human pancreatic cancer. The American journal of pathology 2003; 163: 1001-1011.
25. Zeng H, Datta K, Neid M, Li J, Parangi S and Mukhopadhyay D. Requirement of different signaling pathways mediated by insulin-like growth factor-I receptor for proliferation, invasion, and VPF/VEGF expression in a pancreatic carcinoma cell line. Biochemical and biophysical research communications 2003; 302: 46-55.
26. Ohmura E, Okada M, Onoda N, Kamiya Y, Murakami H, Tsushima T and Shizume K. Insulin-like growth factor I and transforming growth factor alpha as autocrine growth factors in human pancreatic cancer cell growth. Cancer research 1990; 50: 103-107.
27. Renehan AG, Zwahlen M, Minder C, O'Dwyer ST, Shalet SM and Egger M. Insulin-like growth factor (IGF)-I, IGF binding protein-3, and cancer risk: systematic review and meta-regression analysis. Lancet 2004; 363: 1346-1353.
28. Hamajima N, Matsuo K, Saito T, Hirose K, Inoue M, Takezaki T, Kuroishi T and Tajima K. Geneenvironment Interactions and Polymorphism Studies of Cancer Risk in the Hospital-based Epidemiologic Research Program at Aichi Cancer Center II (HERPACC-II). Asian Pac J CancerPrev 2001; 2: 99-107.
29. Inoue M, Tajima K, Hirose K, Hamajima N, Takezaki T, Kuroishi T and Tominaga S. Epidemiological features of first-visit outpatients in Japan: comparison with general population and variation by sex, age, and season. J Clin Epidemiol 1997; 50: 69-77.
30. The International HapMap Project. Nature 2003; 426: 789-796.
31. Thorisson GA, Smith AV, Krishnan L and Stein LD. The International HapMap Project Web site. Genome research 2005; 15: 1592-1593.
32. Marchenko YV, Carroll RJ, Lin DY, Amos CI and Gutierrez RG. Semiparametric analysis of casecontrol genetic data in the presence of environmental factors. Stata Journal 2008; 8: 305-333.
33. Hamajima N, Yuasa H, Matsuo K and Kurobe Y. Detection of gene-environment interaction by case-only studies. Japanese journal of clinical oncology 1999; 29: 490-493.
34. Zhang M, Hu Z, Huang J, Shu Y, Dai J, Jin G, Tang R, Dong J, Chen Y, Xu L, Huang X and Shen H. A 3'-untranslated region polymorphism in IGF1 predicts survival of non-small cell lung cancer in a Chinese population. Clinical cancer research: an official journal of the American Association for Cancer Research 2010; 16: 1236-1244.
35. McElholm AR, McKnight AJ, Patterson CC, Johnston BT, Hardie LJ and Murray LJ. A population- based study of IGF axis polymorphisms and the esophageal inflammation, metaplasia, adenocarcinoma sequence. Gastroenterology 2010; 139: 204-212 e203.
36. Xie L, Gong YY, Lian SG, Yang J, Yang Y, Gao SJ, Xu LY and Zhang YP. Absence of association between SNPs in the promoter region of the insulin-like growth factor 1 (IGF-1) gene and longevity in the Han Chinese population. Experimental gerontology 2008; 43: 962-965.
37. Johansson M, McKay JD, Wiklund F, Rinaldi S, Verheus M, van Gils CH, Hallmans G, Balter K, Adami HO, Gronberg H, Stattin P and Kaaks R. Implications for prostate cancer of insulin-like growth factor-I (IGF-I) genetic variation and circulating IGF-I levels. The Journal of clinical endocrinology and metabolism 2007; 92: 4820-4826.
38. Lin Y, Yagyu K, Egawa N, Ueno M, Mori M, Nakao H, Ishii H, Nakamura K, Wakai K, Hosono S, Tamakoshi A and Kikuchi S. An overview of genetic polymorphisms and pancreatic cancer risk in molecular epidemiologic studies. Journal of epidemiology/Japan Epidemiological Association 2011; 21: 2-12.
39. Suzuki T, Matsuo K, Hasegawa Y, Hiraki A, Kawase T, Tanaka H and Tajima K. Anthropometric factors at age 20 years and risk of thyroid cancer. Cancer causes & control: CCC 2008; 19: 1233-1242.